乾元浩QYH品牌怎么样 申请店铺

我要投票 乾元浩QYH在兽药行业中的票数:634 更新时间:2026-01-23
乾元浩QYH是哪个国家的品牌?「乾元浩QYH」是 乾元浩生物股份有限公司 旗下著名品牌。该品牌发源于北京市,由创始人吴冬荀在2004-07-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力乾元浩QYH品牌出海!将品牌入驻外推网,定制乾元浩QYH品牌推广信息,可以显著提高乾元浩QYH产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

乾元浩QYH怎么样

知名兽药禽药品牌,集兽用生物制品及诊断试剂研发/生产/销售/技术服务/投资及进出口贸易为一体的综合型企业,其重大动物疫病疫苗业界较为有名


乾元浩生物股份有限公司(以下简称“乾元浩”)隶属国有大型中央企业,于2004年7月1日正式在国家工商行政管理总局注册成立,注册资金1.28亿元。乾元浩主营兽用生物制品及诊断试剂的生产、销售、研发、技术服务、项目投资及进出口贸易。

乾元浩是农业部指定生产高致病性禽流感、高致病性猪蓝耳病、猪瘟、狂犬病等重大动物疫病疫苗的企业,在国家防控禽流感、口蹄疫等重大动物疫病过程中做出贡献。旗下拥有三个GMP生产基地——南京生物药厂、郑州生物药厂、北京生物药厂,并参股南京梅里亚动物保健有限公司。南京生物药厂可追溯至1931年,是国内兽用生物制品生产企业。郑州生物药厂成立于1949年,在国内实现禽流感疫苗工业化生产。北京生物药厂成立于1988年;南京梅里亚动物保健有限公司是由法国梅里亚集团和乾元浩共同投资组建的高科技合资企业。

乾元浩目前可生产兽用生物制品及诊断试剂近60个品种、200多个规格,年产动物疫苗200多亿羽(头)份。产品国内市场占有率居行业前列。公司产品已出口印尼、埃及、越南、蒙古等多个国家,与非洲、东南亚及周边等国家建立了经贸合作关系。


Qianyuanhao biological Co., Ltd. (hereinafter referred to as "Qianyuanhao") is a well-known brand of veterinary medicine and poultry medicine, a comprehensive enterprise integrating research and development / production / sales / technical services / investment and import and export trade of veterinary biological products and diagnostic reagents. It is well-known in the vaccine industry of major animal diseases. It is a state-owned large-scale central enterprise. It was officially established in the State Administration for Industry and Commerce on July 1, 2004 The Bureau was registered and established with a registered capital of 128 million yuan. Qianyuanhao is mainly engaged in the production, sales, research and development, technical services, project investment and import and export trade of biological products and diagnostic reagents for animal use. Qianyuanhao is an enterprise designated by the Ministry of agriculture to produce vaccines for major animal diseases such as highly pathogenic avian influenza, highly pathogenic swine blue ear disease, swine fever, rabies, etc. it has made contributions to the national prevention and control of avian influenza, foot-and-mouth disease and other major animal diseases. It has three GMP production bases - Nanjing biopharmaceutical factory, Zhengzhou biopharmaceutical factory and Beijing biopharmaceutical factory, and shares in Nanjing Meiya animal health Co., Ltd. Nanjing biopharmaceutical factory can be traced back to 1931. It is a domestic animal biological product manufacturer. Zhengzhou biopharmaceutical factory was founded in 1949, and industrialized production of avian influenza vaccine was realized in China. Beijing biopharmaceutical factory was founded in 1988. Nanjing meiria animal health Co., Ltd. is a high-tech joint venture jointly invested by meiria group of France and Qianyuanhao. At present, Qianyuanhao can produce nearly 60 varieties and more than 200 specifications of animal biological products and diagnostic reagents, with an annual output of more than 20 billion animal vaccines. The domestic market share of products is in the forefront of the industry. The company's products have been exported to Indonesia, Egypt, Vietnam, Mongolia and other countries, and established economic and trade cooperation relations with Africa, Southeast Asia and surrounding countries.

本文链接: https://brand.waitui.com/3fbd45d6f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

东芯股份:预计2025年净亏损1.74亿元-2.14亿元

36氪获悉,东芯股份发布2025年度业绩预告。报告显示,预计归属于母公司所有者的净亏损1.74亿元-2.14亿元。与上年同期(法定披露数据)相比,亏损增加4.10%-28.03%。

2小时前

航天机电:预计2025年净亏损3.90亿元-5.80亿元

36氪获悉,航天机电发布2025年业绩预告。报告显示,预计2025年度归属于上市公司股东的净利润为亏损3.90亿元到5.80亿元。业绩预亏主要因光伏产业受行业产能过剩、竞争加剧、限电及电价机制调整影响,量价齐跌;汽配产业面临客户需求不及预期及铝价上涨压力;同时光伏业务盈利能力下降,计提资产减值准备。

2小时前

内部人士证实:理想汽车将关闭一些不赚钱门店

理想汽车内部人士表示,理想汽车后续将关闭一些能效低、扩张期铺开的门店,包括不赚钱的商超门店。“目前处于评估阶段,门店关闭数量不详。”这位内部人士说。这里的门店是指零售中心,不包括售后维修中心及授权钣喷中心。(中新经纬)

2小时前

亚钾国际:2025年净利同比预增75.00%-107.00%

36氪获悉,亚钾国际发布2025年业绩预告。报告显示,预计2025年度归属于上市公司股东的净利润为16.60亿元至19.70亿元,比上年同期增长75.00%-107.00%。业绩变动原因:钾肥产销量同比增长,叠加销售价格及毛利率上升。

2小时前

龙芯中科:预计2025年净亏损4.49亿元左右,同比减亏28%

36氪获悉,龙芯中科发布2025年业绩预告。报告显示,预计2025年年度实现归属于母公司所有者的净利润为-4.49亿元左右,与上年同期相比减少亏损1.76亿元左右,同比减亏28%左右。

2小时前

本页详细列出关于乾元浩QYH的品牌信息,含品牌所属公司介绍,乾元浩QYH所处行业的品牌地位及优势。
咨询